Is There Sufficient Evidence to Support the Use of Intravenous N-Acetylcysteine for the Prevention of Contrast Induced Nephropathy?

Journal of pharmacology & clinical research
doi 10.19080/jpcr.2017.02.555583
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Juniper Publishers

Related search

Rationale, Design, and Baseline Characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: A Pragmatic Randomized Controlled Trial to Evaluate the Efficacy of Acetylcysteine for the Prevention of Contrast-Induced Nephropathy

Trials
MedicinePharmacology
2009English

The Standard Dose Versus Double Dose of N-Acetylcysteine to Prevent Contrast-Induced Nephropathy; A Randomized Controlled Clinical Trial

Journal of Nephropathology
Nephrology
2018English

Prevention of Contrast-Induced Acute Kidney Injury: Is Simple Oral Hydration Similar to Intravenous? A Systematic Review of the Evidence

PLoS ONE
Multidisciplinary
2013English

The Choice of the Iodinated Radiographic Contrast Media to Prevent Contrast-Induced Nephropathy

Advances in Nephrology
2014English

Contrast-Induced Nephropathy

2016English

A Prospective Study on Prevention of Contrast – Induced Nephropathy in Croatia

Medicina Fluminensis
Medicine
2019English

Do Intravenous N-Acetylcysteine and Sodium Bicarbonate Prevent High Osmolal Contrast-Induced Acute Kidney Injury? A Randomized Controlled Trial

PLoS ONE
Multidisciplinary
2014English

N-Acetylcysteine Is Effective for Prevention but Not for Treatment of Folic Acid-Induced Acute Kidney Injury in Mice*

Critical Care Medicine
Critical CareIntensive Care Medicine
2011English

In Peritoneal Dialysis, Is There Sufficient Evidence to Make “PD First” Therapy?

International Journal of Nephrology
Nephrology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy